Related Experiment Video
Updated: Jul 14, 2026

A Mobile Outside-in Technique of Transforaminal Lumbar Endoscopy for Lumbar Disc Herniations
Published on: August 7, 2018
High mobility group box 1 as a biomarker for lumbar disc herniation severity in chronic low back pain
Rosa Dwi Wahyuni1, Dachruddin Ngatimin2, M Sabir3
1Department of Clinical Pathology, Faculty of Medicine, Tadulako University, Palu, Indonesia.
Insights
This study found no strong link between herniation severity and High Mobility Group Box 1 (HMGB1) levels in chronic low back pain (LBP) patients. Further research is needed to understand HMGB1's role in LBP.
Area of Science:
- Biomedical Research
- Pain Management
- Inflammatory Cytokines
Background:
- Chronic low back pain (LBP) significantly impacts quality of life.
- High Mobility Group Box 1 (HMGB1), a pro-inflammatory cytokine, is implicated in LBP pathophysiology, particularly nucleus pulposus herniation (NHP).
Purpose of the Study:
- To investigate the correlation between the severity of nucleus pulposus herniation and lumbosacral High Mobility Group Box 1 (HMGB1) levels in patients with chronic low back pain.
Main Methods:
- An analytical observational, cross-sectional study involving 64 chronic LBP patients.
- Serum HMGB1 levels were measured, and herniation severity was assessed using MRI.
- Pain severity was quantified using the Numeric Pain Rating Scale (NPRS).
Main Results:
- Mean HMGB1 level was 4701 (±1001.88).
- HMGB1 levels peaked in Grade 2 herniation (5939.10 ± 873.26).
- Weak correlations were observed between NHP and HMGB1 (r=0.174) and between HMGB1 and NPRS (r=0.114).
Conclusions:
- No significant relationship was established between nucleus pulposus herniation severity and HMGB1 levels in chronic LBP.
- Further research is warranted to elucidate HMGB1's precise role in LBP and its potential as a biomarker.
Introduction:
Chronic low back pain (LBP) is a widespread condition that significantly affects daily life. High mobility group box 1 (HMGB1), a proinflammatory cytokine, may contribute to the pathophysiology of LBP, particularly in relation to nucleus pulposus herniation (NHP). This study aimed to examine the correlation between herniation severity and lumbosacral HMGB1 levels in chronic LBP patients.
Methods:
This analytical observational study with a cross-sectional design was conducted in 2023 at Anutapura General Hospital, Palu. A total of 64 chronic LBP patients participated. Serum HMGB1 levels were measured, and magnetic resonance imaging was used to assess herniation severity. Pain severity was evaluated using the Numeric Pain Rating Scale (NPRS).
Results:
The mean HMGB1 level was 4701 (±1001.88). LBP onset was most common between 4 and 12 months (mean duration: 11.52 ± 5.54 months), with pain more frequently located on the right side (59%). Grade 3 herniation occurred most often (59%), and moderate pain (NPRS score 6) was the most common. HMGB1 levels peaked in Grade 2 herniation (5939.10 ± 873.26). NPRS scores increased with herniation severity, but weak correlations were found between NHP and HMGB1 (r = 0.174) and between HMGB1 and NPRS (r = 0.114).
Conclusions:
No strong relationship was found between NHP and HMGB1 levels in chronic LBP patients. Further studies are needed to clarify HMGB1's role in LBP pathophysiology and its potential as a biomarker for disease severity or treatment response.
More Related Videos
10:09Transtubular Endoscopic Posterolateral Decompression for L5-S1 Lumbar Lateral Disc Herniation
Published on: October 14, 2022
06:28Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation
Published on: December 13, 2024
Related Concept Videos
Herniated Intervertebral Disc l: Introduction
Degenerative Disc Disease I: Introduction
Degenerative Disc Disease ll: Pathophysiology